Trial Parameters
Condition Parkinson Disease
Sponsor Xiangya Hospital of Central South University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2017-02-01
Completion 2027-02-01
Brief Summary
The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria or other standard criteria; PD patients detected with positive LRRK2 variants Exclusion Criteria: \-
Related Trials
NCT06385184
Social & QoL Behaviors in Parkinson's Disease
View Trial →
NCT05884944
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parki
View Trial →
NCT06487364
Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8
View Trial →